Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model von Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W.

Volltext

Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model von Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W.

Volltext

A Clinically Relevant Protocol Induces Tolerance to a Vascularized Composite Allograft Across Major Histocompatibility Barrier In A Large Animal Model von Mathes, David, Swearingen, Bruce J, Graves, Scott S, Storb, Rainer

Volltext

Abstract 12: Achieving Tolerance in a Mismatched VCA Transplant While Reducing the Risk of GVHD: The Goal of Transient Chimerism von Swearingen, Bruce J, Chang, Jeff, Mathes, David W, Butts, Tiffany, Graves, Scott, Storb, Rainer

Volltext

Abstract 12: Achieving Tolerance in a Mismatched VCA Transplant While Reducing the Risk of GVHD von Swearingen, Bruce J, Chang, Jeff, Mathes, David W, Butts, Tiffany, Graves, Scott, Storb, Rainer

Volltext

Abstract 48: A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using A Single Dose of AMD3100 for Stem Cell Mobilization von Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W.

Volltext

Simultaneous bone marrow and tissue transplantation in rats treated with a nonmyeloablative conditioning regimen promote tolerance to composite tissue allografts (141.18) von Ramsey, Deborah M., Bozulic, Larry D., Wu, Shengli, Adamson, Larry A., Rahhal, Dina N., Swearingen, Bruce J., Xu, Hong, Ildstad, Suzanne T.

Volltext

A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and delivery von Garite, Thomas J., MD, Combs, C. Andrew, MD, PhD, Maurel, Kimberly, MSN, Das, Anita, PhD, Huls, Kevin, MD, MSc, Porreco, Richard, MD, Reisner, Dale, MD, Lu, George, MD, Bush, Melissa, MD, Morris, Bruce, MD, Bleich, April, MD

Volltext

Abstract 122: MISMATCHED VCA TRANSPLANTATION WITHOUT THE NEED FOR DONOR CELL CHIMERISM: A MODEL TO ACHIEVE TOLERANCE WHILE ELIMINATING CHRONIC IMMUNOSUPPRESSION AND THE RISKS OF GV... von Swearingen, Bruce, Chang, J, Graves, S, Hwang, B, Miwongtum-Butts, T, Storb, R, Mathes, DW

Volltext

Abstract 122: MISMATCHED VCA TRANSPLANTATION WITHOUT THE NEED FOR DONOR CELL CHIMERISM von Swearingen, Bruce, Chang, J, Graves, S, Hwang, B, Miwongtum-Butts, T, Storb, R, Mathes, DW

Volltext

Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity von Castilleja, A, Ward, N E, O'Brian, C A, Swearingen, 2nd, B, Swan, E, Gillogly, M A, Murray, J L, Kudelka, A P, Gershenson, D M, Ioannides, C G

Volltext

Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity von Castilleja, Agapito, Ward, Nancy E, O'brian, Catherine A, Swearingen, Bruce, Swan, Eric, Gillogly, Michal A, Murray, James L, Kudelka, Andrzej P, Gershenson, David M, Ioannides, Constantin G

Volltext